Coll Crespo Blas (CIK 2037144) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-23). Recent activity: Buy GPCR (75,897 shares), Sell GPCR (11,826 shares), Sell GPCR (8,106 shares), Sell GPCR (1,233 shares), Buy GPCR (7,992 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-23 | Structure Therapeutics Inc. (GPCR) | CHIEF MEDICAL OFFICER | Buy | 75,897 | $0 |
| 2026-03-05 | Structure Therapeutics Inc. (GPCR) | CHIEF MEDICAL OFFICER | Sell | 11,826 | $248,228 |
| 2025-09-22 | Structure Therapeutics Inc. (GPCR) | CHIEF MEDICAL OFFICER | Sell | 8,106 | $62,740 |
| 2025-07-03 | Structure Therapeutics Inc. (GPCR) | CHIEF MEDICAL OFFICER | Sell | 1,233 | $9,765 |
| 2025-07-03 | Structure Therapeutics Inc. (GPCR) | CHIEF MEDICAL OFFICER | Buy | 7,992 | $0 |
| 2025-07-03 | Structure Therapeutics Inc. (GPCR) | CHIEF MEDICAL OFFICER | Sell | 1,434 | $9,809 |
| 2025-03-18 | Structure Therapeutics Inc. (GPCR) | Chief Medical Officer | Buy | 116,988 | $0 |
Source: SEC Form 4 filings · as of 2026-03-23